封面
市场调查报告书
商品编码
1442909

角膜植入物 - 全球市场考量、竞争格局、市场预测 (2030)

Corneal Implant - Market Insights, Competitive Landscape, and Market Forecast - 2030

出版日期: | 出版商: DelveInsight | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

预计2024-2030年预测期内,全球角膜植入物市场规模将以6.43%的复合年增长率大幅成长。对角膜植入物的需求主要是由角膜失明、眼外伤和高眼压(青光眼)病例数量的增加所推动的。此外,预计2024-2030年预测期内,各行业参与者在角膜植入物开发方面的合作活动不断增加以及角膜捐赠者的稀缺将有助于市场的整体成长。

角膜植入物市场动态

根据BrightFocus Foundation(2022)提供的数据,全球有 8,000 万人患有青光眼,预计到 2040 年这一数字将增加到 1.11 亿以上。根据同一消息来源,失明或低视力影响着 330 万 40 岁以上的美国人。此外,世界卫生组织(WHO)发布的最新研究数据得出结论,角膜失明是继青光眼和白内障之后的第三大失明原因,影响全球约1000万人。

因此,青光眼、角膜失明等眼科疾病的盛行率不断增加,产生了对角膜植入物的需求,从而导致角膜植入物市场的积极增长。

角膜捐赠者数量有限也是角膜植入市场的驱动因素之一。例如,根据American Academy of Ophthalmology(2021)的数据,大约有 1,000 万人需要角膜移植,因此世界各地对角膜捐赠者的需求很高。因此,角膜捐赠者的数量少或稀缺在推动角膜植入市场方面发挥着至关重要的作用。

然而,人造角膜的排斥和与设备相关的高成本是可能限制角膜植入物市场成长的市场障碍。

角膜植入物市场细分分析

在角膜植入市场的手术领域,全层角膜移植类别预计将在 2023 年获得可观的收入占有率。这可能是由于全层角膜移植术提供的各种优点。

全层角膜移植术,也称为角膜移植,涉及透过手术切除角膜的疾病或受损区域,然后用健康组织取代它。这项手术可以帮助缓解疼痛、改善视力并治疗严重感染或角膜区域损伤。

根据Eye Bank Association of America(2022)的数据,2021 年美国用于全层角膜移植的循环组织总数为 79,641 份。上述数字清楚地显示了对全层角膜移植的需求和需求不断增长。

因此,由于上述因素,预计全层角膜植入物类别将显着成长,从而推动预测期内整体角膜植入物市场的成长。

预计北美将主导整个角膜植入市场

在所有地区中,预计到 2023 年,北美将在角膜植入物市场中占最大占有率。这可以归因于该地区主要市场参与者的存在。此外,有效的报销政策、与角膜植入物相关的研发活动的增加以及角膜失明负担的增加也促进了北美角膜植入物市场的成长。

根据美国疾病管制与预防中心(2022)发布的数据,估计2017年约有600万美国人视力丧失,100万美国人失明。此外,糖尿病和高血压等眼科疾病危险因子的盛行率不断增加,导致眼科疾病的盛行率增加,从而增加了对角膜植入物的需求。根据美国疾病管制与预防中心 (CDC, 2020) 的National Diabetics Statistics Report,2020 年约有 3,420 万美国人患有糖尿病。报告也指出,大约 8,800 万美国人患有糖尿病前期。因此,美国眼部疾病负担的增加导致角膜植入物市场的成长加快,进一步推动了北美角膜植入物市场的成长。

本报告提供了全球角膜植入物市场的研究和分析,包括市场规模和预测、驱动因素和挑战以及公司和产品概况。

目录

第一章 角膜植入市场报告简介

第二章角膜植入市场执行摘要

  • 调查范围
  • 市场概况
  • 竞争评估

第三章 监管分析

  • 美国
  • 欧洲
  • 日本
  • 中国

第四章角膜植入市场关键因素分析

  • 角膜植入物市场驱动因素
  • 角膜植入物市场限制与挑战
  • 角膜植入物市场机会

第五章 角膜植入市场的波特五力分析

第六章 角膜植入物市场布局

  • 依程式
    • 内皮角膜移植手术
    • 全层角膜移植
    • 其他
  • 依疾病分类
    • 圆锥角膜
    • 福克斯营养不良症
    • 传染性角膜炎
    • 角膜溃疡
  • 依最终用户
    • 医院
    • 眼科诊所
    • 门诊手术中心
  • 区域
    • 北美
    • 欧洲
    • 亚太地区
    • 其他地区

第七章角膜植入物市场公司与产品概况

  • EyeYon
  • AJL Ophthalmic S.A.
  • KeraMed, Inc.
  • Aurolab
  • CorneaGen
  • Presbia PLC
  • LinkoCare Life Sciences AB
  • MEDIPHACOS
  • Cornea Biosciences
  • Advancing Sight Network
  • Corneat Vision
  • DIOPTEX

第8章 KOL观点

第9章 专案方法

第10章 DelveInsight服务内容

第 11 章关于 DelveInsight

第 12 章免责声明,联络我们

Product Code: DIMDCL0695

Corneal Implants Market By Procedure (Endothelial Keratoplasty, Penetrating Keratoplasty, And Others), Disease (Keratoconus, Fuchs Dystrophy, Infectious Keratitis, Corneal Ulcers, And Others), End-User (Hospitals, Eye Clinics, And Ambulatory Surgical Centers) and geography is expected to grow at a steady CAGR forecast till 2030 owing to the increasing incidence of corneal blindness, eye injury, and other ophthalmic disorders and rising partnership activities for the development of corneal implants combined with increasing technological advancements in product design

The global Corneal Implants Market is poised for significant growth, projected to achieve a remarkable Compound Annual Growth Rate (CAGR) of 6.43% during the forecast period from 2024 to 2030. The demand for corneal implants is primarily being boosted by the increasing cases of corneal blindness, eye injuries, ocular hypertension (glaucoma), and among others. Additionally, the rising partnership activities among various industry players for the development of corneal implants and the scarce number of cornea donors are expected to contribute to the overall growth of the corneal implants market during the forecast period from 2024-2030.

Corneal Implants Market Dynamics:

According to data provided by BrightFocus Foundation 2022, globally 80 million people are suffering from glaucoma and this number is expected to increase to over 111 million by the year 2040. As per the same source, blindness or low vision affects 3.3 million Americans after the age of 40 years. Additionally, as per the data published by the World Health Organization (WHO) in the latest study, it was concluded that corneal blindness is the third-leading cause of blindness after glaucoma and cataracts affecting around 10 million people globally.

Thus the rising prevalence of ophthalmic disorders such as glaucoma, corneal blindness, and other disorders, will create a need for corneal implants, thus resulting in the positive growth of the Corneal Implants market.

The presence of only a minimal number of corneal donors is another driver for the Corneal Implants market. For instance, according to the American Academy of Ophthalmology 2021, there is a high demand for corneal donors around the world as nearly 10 million people need corneal transplants. Thus, the presence of a low or scarce number of cornea donors will play a pivotal role in driving the Corneal Implants Market.

However, the rejection of artificial corneas and, the high costs associated with the device, are some of the market barriers that may restrict the growth of the corneal implants market.

Corneal Implants Market Segment Analysis:

Corneal Implants Market by Procedure (Endothelial Kertoplasty, Penetrating Keratoplasty, and Others), Disease (Keratoconus, Fuchs Dystrophy, Infectious Keratitis, Corneal Ulcers, and Others), End-User (Hospitals, Eye Clinics, and Ambulatory Surgical Centers), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the procedure segment of the Corneal Implants market, the Penetrating Keratoplasty category is expected to amass a significant revenue share in the year 2023. This can be attributed to the various advantages provided by the penetrating keratoplasty procedures.

Penetrating Keratoplasty also known as corneal transplant or corneal graft is the surgical removal of diseased or damaged portion of the cornea, which is followed by implantation of healthy tissue. The procedure helps to relieve pain, improve sight, and treat severe infection or damage in the corneal region.

According to the Eye Bank Association of America 2022, the total number of U.S.-supplied tissue distributed for penetrating keratoplasty was 79,641 in 2021. The above-mentioned figure highlights the rising demand and the need for penetrating keratoplasty procedures.

Therefore, owing to the above-mentioned factors, the penetrating keratoplasty category is expected to register significant growth, thereby driving the growth of the overall Corneal Implants market during the forecast period.

North America is expected to dominate the overall Corneal Implants Market:

Among all the regions, North America is estimated to account for the largest share of the Corneal Implants market in the year 2023. This can be attributed to the presence of major market players in the region. Additionally, efficient reimbursement policies, increasing R&D activities related to corneal implants, and increasing burden of corneal blindness are some of the contributing factors to the growth of the Corneal Implants market in North America.

According to the data published by the Centers of Disease Control and Prevention 2022, it was estimated that approximately 6 million Americans had vision loss and 1 million Americans was suffering from blindness in 2017. Additionally, increasing the prevalence of risk factors of ophthalmic disorders such as diabetes and hypertension in turn will increase the prevalence of ophthalmic disorders and ultimately increase the demand for corneal implants. As per the National Diabetics Statistics Report by the Centers for Disease Control and Prevention (CDC, 2020), about 34.2 million Americans had diabetes in 2020. The report further stated that approximately 88 million Americans showed pre-diabetes levels. Thus, the increasing burden of ocular disorders in the United States will eventually lead to an increase in the growth of the corneal implants market, which will further propel the market for corneal implants market in North America.

Moreover, the occurrence of various product development and partnership activities in the region is another driving factor for the corneal implants market. For Instance, in July 2022 Carl Zeiss Meditec and Precise Bio announced an agreement for the development and commercialization of tissue-based implants.

Thus, the factors mentioned above, are thereby responsible for driving the Corneal Implants market in the United States, which will further boost the market for Corneal Implants in North America during the forecast period.

Corneal Implants Market Key Players:

Some of the key market players operating in the Corneal Implants Market include EyeYon, AJL Ophthalmic S.A., KeraMed, Inc., Aurolab, CorneaGen, Presbia PLC, LinkoCare Life Sciences AB, MEDIPHACOS, Cornea Biosciences, Advancing Sight Network, Corneat Vision, DIOPTEX, among others.

Recent Developmental Activities in the Corneal Implants Market:

  • In July 2022, Acufocus received FDA approval for AcuFocus' IC-8 Apthera. IC-8 Apthera is indicated for the treatment of cataract patients.
  • In July 2019, CorneaGen received USD 37 million in funding for the advanced development of Cornea Cell Therapy.

Key Takeaways from the Corneal Implants Market Report Study

  • Market size analysis for current Corneal Implants Market size (2023), and market forecast for 6 years (2024-2030)
  • Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years
  • Key companies dominating the global Corneal Implants market.
  • Various opportunities available for the other competitors in the Corneal Implants Market space.
  • What are the top-performing segments in 2023? How these segments will perform in 2030?
  • Which are the top-performing regions and countries in the current Corneal Implants Market scenario?
  • Which are the regions and countries where companies should have concentrated on opportunities for Corneal Implants Market growth in the coming future?

Target Audience who can be benefited from this Corneal Implants Market Report Study

  • Corneal Implants product providers
  • Research organizations and consulting companies
  • Corneal Implant -related organizations, associations, forums, and other alliances
  • Government and corporate offices
  • Start-up companies, venture capitalists, and private equity firms
  • Distributors and Traders dealing in Corneal Implants
  • Various end-users who want to know more about the Corneal Implants Market and the latest technological developments in the Corneal Implants Market.

Frequently Asked Questions for the Corneal Implants Market:

1 What is meant by Corneal Implants?

Corneal Implants are artificial corneas usually used to replace the diseased cornea of the eye via endothelial keratoplasty, penetrating keratoplasty, and other ophthalmic procedures. It is mostly used to treat ocular conditions such as corneal ulcers, corneal blindness and Fuchs Dystrophy.

2 What is the market for global Corneal Implants Market?

The global Corneal Implants Market is poised for significant growth, projected to achieve a remarkable Compound Annual Growth Rate (CAGR) of 6.43% during the forecast period from 2024 to 2030.

3 What are the drivers for the global Corneal Implants market?

The Corneal Implants Market is slated to witness prosperity owing to factors such as the growing incidence of corneal blindness, eye injury, and other ophthalmic procedures. Additionally, scare number of cornea donors and rising number of partnerships for the development of corneal implants, are some of the factors which can result in appreciable revenue growth in the Corneal Implants Market during the forecast period (2024-2030).

4 Who are the key players operating in the global Corneal Implants market?

Some of the key market players operating in the Corneal Implants Market include EyeYon, AJL Ophthalmic S.A., KeraMed, Inc., Aurolab, CorneaGen, Presbia PLC, LinkoCare Life Sciences AB, MEDIPHACOS, Cornea Biosciences, Advancing Sight Network, Corneat Vision, DIOPTEX, among others.

5. Which region has the highest share in the global Corneal Implants market?

North America is expected to dominate the overall Corneal Implants Market during the forecast period, 2024 to 2030. This can be attributed to the presence of major players in the region, efficient reimbursement policies, increasing R&D activities related to corneal implants, increasing burden of corneal blindness, and rising elderly population prone to ophthalmic diseases are some of the factors influencing the positive growth of the market in the region during the forecast period.

Table of Contents

1. Corneal Implants Market Report Introduction

2. Corneal Implants Market Executive Summary

  • 2.1. Scope of the Study
  • 2.2. Market at Glance
  • 2.3. Competitive Assessment

3. Regulatory Analysis

  • 3.1. The United States
  • 3.2. Europe
  • 3.3. Japan
  • 3.4. China

4. Corneal Implants Market Key Factors Analysis

  • 4.1. Corneal Implants Market Drivers
    • 4.1.1. Increasing incidence of corneal blindness, eye injury and other ophthalmic disorders
    • 4.1.2. Low number of cornea donors
    • 4.1.3. Rising number of partnership activities for the development of corneal implants
  • 4.2. Corneal Implants Market Restraints and Challenges
    • 4.2.1. Rejection of Artificial Corneas
    • 4.2.2. High Cost of devices
  • 4.3. Corneal Implants Market Opportunities
    • 4.3.1. Improving product safety and biocompatibility
    • 4.3.2. Rising development of 3D printed artificial corneas

5. Corneal Implants Market Porter's Five Forces Analysis

  • 5.1. Bargaining Power of Suppliers
  • 5.2. Bargaining Power of Consumers
  • 5.3. Threat of New Entrants
  • 5.4. Threat of Substitutes
  • 5.5. Competitive Rivalry

6. Corneal Implants Market Layout

  • 6.1. By Procedure
    • 6.1.1. Endothelial Kertoplasty
    • 6.1.2. Penetrating Keratoplasty
    • 6.1.3. Others
  • 6.2. By Disease
    • 6.2.1. Keratoconus
    • 6.2.2. Fuchs Dystrophy
    • 6.2.3. Infectious Keratitis
    • 6.2.4. Corneal Ulcers
    • 6.2.5. Others
  • 6.3. By End-User
    • 6.3.1. Hospitals
    • 6.3.2. Eye Clinics
    • 6.3.3. Ambulatory Surgical Centers
  • 6.4. By Geography
    • 6.4.1. North America
      • 6.4.1.1. United States Corneal Implants Market Size in USD million (2021-2030)
      • 6.4.1.2. Canada Corneal Implants Market Size in USD million (2021-2030)
      • 6.4.1.3. Mexico Corneal Implants Market Size in USD million (2021-2030)
    • 6.4.2. Europe
      • 6.4.2.1. France Corneal Implants Market Size in USD million (2021-2030)
      • 6.4.2.2. Germany Corneal Implants Market Size in USD million (2021-2030)
      • 6.4.2.3. United Kingdom Corneal Implants Market Size in USD million (2021-2030)
      • 6.4.2.4. Italy Corneal Implants Market Size in USD million (2021-2030)
      • 6.4.2.5. Spain Corneal Implants Market Size in USD million (2021-2030)
      • 6.4.2.6. Rest of Europe Corneal Implants Market Size in USD million (2021-2030)
    • 6.4.3. Asia-Pacific
      • 6.4.3.1. China Corneal Implants Market Size in USD million (2021-2030)
      • 6.4.3.2. Japan Corneal Implants Market Size in USD million (2021-2030)
      • 6.4.3.3. India Corneal Implants Market Size in USD million (2021-2030)
      • 6.4.3.4. Australia Corneal Implants Market Size in USD million (2021-2030)
      • 6.4.3.5. South Korea Corneal Implants Market Size in USD million (2021-2030)
      • 6.4.3.6. Rest of Asia-Pacific Corneal Implants Market Size in USD million (2021-2030)
    • 6.4.4. Rest of the World (RoW)
      • 6.4.4.1. Middle East Corneal Implants Market Size in USD million (2021-2030)
      • 6.4.4.2. Africa Corneal Implants Market Size in USD million (2021-2030)
      • 6.4.4.3. South America Corneal Implants Market Size in USD million (2021-2030)

7. Corneal Implants Market Company and Product Profiles

  • 7.1. EyeYon
    • 7.1.1. Company Overview
    • 7.1.2. Company Snapshot
    • 7.1.3. Financial Overview
    • 7.1.4. Product Listing
    • 7.1.5. Entropy
  • 7.2. AJL Ophthalmic S.A.
    • 7.2.1. Company Overview
    • 7.2.2. Company Snapshot
    • 7.2.3. Financial Overview
    • 7.2.4. Product Listing
    • 7.2.5. Entropy
  • 7.3. KeraMed, Inc.
    • 7.3.1. Company Overview
    • 7.3.2. Company Snapshot
    • 7.3.3. Financial Overview
    • 7.3.4. Product Listing
    • 7.3.5. Entropy
  • 7.4. Aurolab
    • 7.4.1. Company Overview
    • 7.4.2. Company Snapshot
    • 7.4.3. Financial Overview
    • 7.4.4. Product Listing
    • 7.4.5. Entropy
  • 7.5. CorneaGen
    • 7.5.1. Company Overview
    • 7.5.2. Company Snapshot
    • 7.5.3. Financial Overview
    • 7.5.4. Product Listing
    • 7.5.5. Entropy
  • 7.6. Presbia PLC
    • 7.6.1. Company Overview
    • 7.6.2. Company Snapshot
    • 7.6.3. Financial Overview
    • 7.6.4. Product Listing
    • 7.6.5. Entropy
  • 7.7. LinkoCare Life Sciences AB
    • 7.7.1. Company Overview
    • 7.7.2. Company Snapshot
    • 7.7.3. Financial Overview
    • 7.7.4. Product Listing
    • 7.7.5. Entropy
  • 7.8. MEDIPHACOS
    • 7.8.1. Company Overview
    • 7.8.2. Company Snapshot
    • 7.8.3. Financial Overview
    • 7.8.4. Product Listing
    • 7.8.5. Entropy
  • 7.9. Cornea Biosciences
    • 7.9.1. Company Overview
    • 7.9.2. Company Snapshot
    • 7.9.3. Financial Overview
    • 7.9.4. Product Listing
    • 7.9.5. Entropy
  • 7.10. Advancing Sight Network
    • 7.10.1. Company Overview
    • 7.10.2. Company Snapshot
    • 7.10.3. Financial Overview
    • 7.10.4. Product Listing
    • 7.10.5. Entropy
  • 7.11. Corneat Vision
    • 7.11.1. Company Overview
    • 7.11.2. Company Snapshot
    • 7.11.3. Financial Overview
    • 7.11.4. Product Listing
    • 7.11.5. Entropy
  • 7.12. DIOPTEX
    • 7.12.1. Company Overview
    • 7.12.2. Company Snapshot
    • 7.12.3. Financial Overview
    • 7.12.4. Product Listing
    • 7.12.5. Entropy

8. KOL Views

9. Project Approach

10. DelveInsight Capabilities

11. About DelveInsight

12. Disclaimer & Contact Us

List of Tables

  • Table 1: Competitive Analysis
  • Table 2: Corneal Implants Market in Global (2021-2030)
  • Table 3: Corneal Implants Market in Global by Procedure (2021-2030)
  • Table 4: Corneal Implants Market in Global by Disease (2021-2030)
  • Table 5: Corneal Implants Market in Global by End-User (2021-2030)
  • Table 6: Corneal Implants Market in Global by Geography (2021-2030)
  • Table 7: Corneal Implants Market in North America (2021-2030)
  • Table 8: Corneal Implants Market in North America by Country (2021-2030)
  • Table 9: Corneal Implants Market in the United States (2021-2030)
  • Table 10: Corneal Implants Market in Canada (2021-2030)
  • Table 11: Corneal Implants Market in Mexico (2021-2030)
  • Table 12: Corneal Implants Market in Europe (2021-2030)
  • Table 13: Corneal Implants Market in Europe by Country (2021-2030)
  • Table 14: Corneal Implants Market in France (2021-2030)
  • Table 15: Corneal Implants Market in Germany (2021-2030)
  • Table 16: Corneal Implants Market in the United Kingdom (2021-2030)
  • Table 17: Corneal Implants Market in Italy (2021-2030)
  • Table 18: Corneal Implants Market in Spain (2021-2030)
  • Table 19: Corneal Implants Market in the Rest of Europe (2021-2030)
  • Table 20: Corneal Implants Market in Asia-Pacific (2021-2030)
  • Table 21: Corneal Implants Market in Asia-Pacific by Country (2021-2030)
  • Table 22: Corneal Implants Market in China (2021-2030)
  • Table 23: Corneal Implants Market in Japan (2021-2030)
  • Table 24: Corneal Implants Market in India (2021-2030)
  • Table 25: Corneal Implants Market in Australia (2021-2030)
  • Table 26: Corneal Implants Market in South Korea (2021-2030)
  • Table 27: Corneal Implants Market in Rest of Asia-Pacific (2021-2030)
  • Table 28: Corneal Implants Market in the Rest of the World (2021-2030)
  • Table 29: Corneal Implants Market in RoW by Region (2021-2030)
  • Table 30: Corneal Implants Market in the Middle East (2021-2030)
  • Table 31: Corneal Implants Market in Africa (2021-2030)
  • Table 32: Corneal Implants Market in South America (2021-2030)

List of Figures

  • Figure 1: Competitive Analysis
  • Figure 2: Corneal Implants Market in Global (2021-2030)
  • Figure 3: Corneal Implants Market in Global by Procedure (2021-2030)
  • Figure 4: Corneal Implants Market in Global by Disease (2021-2030)
  • Figure 5: Corneal Implants Market in Global by End-User (2021-2030)
  • Figure 6: Corneal Implants Market in Global by Geography (2021-2030)
  • Figure 7: Corneal Implants Market in North America (2021-2030)
  • Figure 8: Corneal Implants Market in North America by Country (2021-2030)
  • Figure 9: Corneal Implants Market in the United States (2021-2030)
  • Figure 10: Corneal Implants Market in Canada (2021-2030)
  • Figure 11: Corneal Implants Market in Mexico (2021-2030)
  • Figure 12: Corneal Implants Market in Europe (2021-2030)
  • Figure 13: Corneal Implants Market in Europe by Country (2021-2030)
  • Figure 14: Corneal Implants Market in France (2021-2030)
  • Figure 15: Corneal Implants Market in Germany (2021-2030)
  • Figure 16: Corneal Implants Market in the United Kingdom (2021-2030)
  • Figure 17: Corneal Implants Market in Italy (2021-2030)
  • Figure 18: Corneal Implants Market in Spain (2021-2030)
  • Figure 19: Corneal Implants Market in the Rest of Europe (2021-2030)
  • Figure 20: Corneal Implants Market in Asia-Pacific (2021-2030)
  • Figure 21: Corneal Implants Market in Asia-Pacific by Country (2021-2030)
  • Figure 22: Corneal Implants Market in China (2021-2030)
  • Figure 23: Corneal Implants Market in Japan (2021-2030)
  • Figure 24: Corneal Implants Market in India (2021-2030)
  • Figure 25: Corneal Implants Market in Australia (2021-2030)
  • Figure 26: Corneal Implants Market in South Korea (2021-2030)
  • Figure 27: Corneal Implants Market in Rest of Asia-Pacific (2021-2030)
  • Figure 28: Corneal Implants Market in the Rest of the World (2021-2030)
  • Figure 29: Corneal Implants Market in RoW by Region (2021-2030)
  • Figure 30: Corneal Implants Market in the Middle East (2021-2030)
  • Figure 31: Corneal Implants Market in Africa (2021-2030)
  • Figure 32: Corneal Implants Market in South America (2021-2030)
  • Figure 33: Market Drivers
  • Figure 34: Market Barriers
  • Figure 35: Marker Opportunities
  • Figure 36: PORTER'S Five Force Analysis